Glory Health appoints Houlihan Lokey to pursue offshore debt restructuring

• Glory Health Industry appointed Houlihan Lokey (China) to evaluate restructuring options amid a liquidity crunch, according to its October 30, 2026 update.
• Outstanding principal on its 2022 Senior Notes totals US$ 334.79 million; the group is seeking an overall debt solution.
• Foshan Shengpingli is in court-supervised reorganization, with the group seeking investors to advance restructuring.
• A proposal from Orient Asset Management for joint acquisition of claims is under review for the Nanshan project.
• Huarong Guangdong is willing to sell its claims; the group plans to seek AMC financing, subject to underlying asset disposals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Glory Health Industry Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261030-12390535), on October 30, 2026, and is solely responsible for the information contained therein.